🧪 Bacteriostatic water — needed to reconstitute the lyophilized vial
💰 Buy by volume
3+ items
Save 10%
★ Wholesale
10+ of one
Save 35%
Discount applied automatically at checkout.
🧪 COA❄️ Cold chain🛡️ Replacement guarantee🔒 Secure payment📦 Nationwide shipping🇺🇸 cGMP · ISO 9001 guidelines · COA
Erythropoietin-derived peptide without hematopoietic effects — neuroprotector and tissue repair agent with unique safety profile.
Mechanism: EPO-derived peptide that activates the innate repair receptor, without affecting hematocrit.
Evidence: Phase 2 human trials (small-fiber neuropathy, sarcoidosis, diabetic neuropathy).
In context: Investigational; generally well tolerated in trials.
Research range · SC
4 mg per application· once daily
🟢 Clinical evidence· Phase 2b
Ranges cited in research literature. Not a usage recommendation. For research use only.
📋 Technical datasheet · Compound specifications
Compound
ARA-290 Cibinetide
Origin
🇺🇸 From US-based suppliers that follow strict cGMP & ISO 9001 guidelines
Form
Lyophilized in sterile vial (or pre-mixed solution depending on SKU)
Molecular formula
C53H74N12O14
Molecular weight
1111.23 g/mol
Sequence
11-mer EPO-derived peptide
Purity
≥99% by HPLC + mass spectrometry (Janoshik Analytical)
Storage
Lyophilized: −20°C to −80°C, dry, dark · Reconstituted: 2–8°C · stability varies by peptide (see the reconstitution guide and the batch COA)
Recommended solvent
Bacteriostatic water (0.9% benzyl alcohol) or 0.9% saline
Cold chain
2–8°C in transit · controlled thermal packaging
Use
Research Use Only (RUO). Not intended for human or veterinary use.
Typical values for this compound category. For product-specific data, see the corresponding COA at /en/coa/.
🧪 Independent third-party analysis available — Janoshik Analytical (HPLC + MS).View all COAs →
This product is exclusively for research purposes. Not intended for human use, consumption, or therapeutic applications. For laboratory use only under qualified supervision.